Introduction {#sec1-1}
============

Primary lung cancer is the leading cause of cancer-related death worldwide (Jemal et al., 2011). Most lung cancer cases (85%) are categorized as non-small cell lung cancer (NSCLC) (Jemal et al., 2011).

It has been well accepted that inflammatory cells are an essential component of the tumor microenvironment, the inflammatory response serve as a crucial role in cancer development and progression and may be associated with systemic inflammation (Mantovani et al., 2008). Emerging evidence suggests that the inflammatory markers have significant correlations with the poor prognosis in NSCLC (Jing et al., 2015; Jin et al., 2017; Gu et al., 2015; Qiang et al., 2016; Okada et al., 2017). One of the most known markers of systemic inflammation is serum C-reactive protein (CRP) level. A meta-analysis clarified that high CRP level is relevant to poorer survival of NSCLC patients and might be used as a prognostic biomarker for NSCLC (Jing et al., 2015). Furthermore, the combination of some parameters, including Glasgow prognostic score (GPS), neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and prognostic nutritional index (PNI), has been used in the prognosis of NSCLC (Jin et al., 2017; Gu et al., 2015; Qiang et al., 2016; Okada et al., 2017). These biomarkers may be used as practical predictors in the daily clinical work.

Recently, a new inflammatory prognostic index (IPI), based on CRP, NLR and serum albumin was introduced as a novel and promising prognostic marker in all stage NSCLC patients (Dirican et al., 2016). They concluded that IPI may be an inexpensive, easily accessible and independent prognostic index for NSCLC patients (Dirican et al., 2016). However, 79.4% of their patients were stage III-IV disease. To our knowledge, there are no previous studies that evaluated the significance of IPI for resected NSCLC. Therefore, in the present study, we examined the prognostic significance of IPI in patients with resected NSCLC.

Materials and Methods {#sec1-2}
=====================

Patients and Methods {#sec2-1}
--------------------

This retrospective study examined the records of a sequential series of 381 patients with NSCLC between January 2008 and December 2012 in our center. There were 173 men and 168 women (median age: 69 years old). The inclusion criteria were as following: histologically confirmed NSCLC and complete clinical, laboratory, imaging and follow-up data. The exclusion criteria included: preoperative chemotherapy/radiotherapy or died perioperative period, clinical evidence of infection or other bone marrow, hematological or autoimmune disease. This retrospective study was approved by Medical Ethics Committee of our hospital. Complete blood count and routine biochemistry test, including serum CRP, serum albumin, serum carcinoembryonic antigen (CEA) and serum cytokeratin 19 fragments (CYFRA21-1), of each patient was applied 1 week before surgery. All patients in this study were staged according to the 8th edition Cancer Staging (Goldstraw et al., 2016). The IPI was calculated as CRP (mg/L) × NLR/serum albumin (g/L) (Dirican et al., 2016). The optimal cut-off value of IPI for overall cancer-specific survival was determined by Cutoff Finder (<http://molpath.charite.de/cutoff>) (Budczies et al., 2012).

Association between categorical variables was assessed using the Fisher's exact test. Cancer-specific survival curves were plotted using the Kaplan--Meier method, with comparisons between groups performed using the log-rank test. Cox regression models were used to assess the relationships between the IPI and cancer-specific survival. After univariate analysis, a multivariate analysis was carried out by Cox regression model. Estimated hazard ratios, their 95% confidence intervals (95% CI), and p values were calculated from the Cox proportional hazard regression models. Statistical analyses were performed using JMP (SAS Institute Inc., Cary, NC, USA). Differences were considered statistically significant when p \< 0.05.

Results {#sec1-3}
=======

Analysis using the Cutoff Finder showed the recommended cutoff values of preoperative IPI for evaluating cancer-specific survival was 5.237. There were 213 (62.46%) patients with low IPI group and 128 (37.53%) patients with high IPI group. The relationships between IPI and clinical characteristics were shown in [Table 1](#T1 T2){ref-type="table"}. In the present series, IPI was significantly associated with age (p=0.008), gender (p\<0.001), smoking status (p\<0.001), histology (p\<0.001), pT status (p=0.049) and CYFRA21-1 (p=0.001), but not pStage (p=0.085), pN status (p=0.409) and serum CEA level (p=0.93).

###### 

Clinical Characteristics of Patients based on the IPI

                    IPI   P-Value   
  ----------------- ----- --------- ---------
  Age                               
   \<65             77    29        0.008
   ≥65              136   99        
  Gender                            
   Male             85    88        \<0.001
   Female           128   40        
  Smoking status                    
   Never            122   36        \<0.001
   Current/former   91    92        
  Histology                         
   AD               186   82        \<0.001
   SCC              13    30        
   Others           14    16        
  pStage                            
   I                172   93        0.085
   II-III           41    35        
  pT status                         
   pT1              155   80        0.049
   pT2-3            58    48        
  pN status                         
   pN0              185   107       0.409
   pN1-2            28    21        
  Serum CEA                         
   Normal           159   95        0.93
   High             54    33        
  CYFRA21-1                         
   Normal           188   95        0.001
   High             25    33        

IPI, inflammatory prognostic index; CEA, carcinoembryonic antigen; CYFRA21-1, cytokeratin 19 fragments; AD, adenocarcinoma; SCC, squamous cell carcinoma.

###### 

Univariate Analysis

                   Favorable   Unfavorable      Hazard ratio   P-Value   95% confidence interval   
  ---------------- ----------- ---------------- -------------- --------- ------------------------- -------
  Age              \<65        ≥65              0.755          0.235     0.461                     1.193
  Gender           Female      Male             0.329          \<0.001   0.204                     0.514
  Smoking status   Never       Current/former   0.349          \<0.001   0.215                     0.549
  Histology        AD          SCC              0.26           \<.0001   0.162                     0.43
                   AD          Others           0.234          \<.0001   0.135                     0.432
                   SCC         Others           0.9            0.751     0.477                     1.755
  pT status        pT1         pT2-3            0.45           \<0.001   0.298                     0.683
  pN status        pN0         pN1-2            0.33           \<0.001   0.211                     0.534
  CEA              Normal      High             0.382          \<0.001   0.252                     0.586
  CYFRA21-1        Normal      High             0.353          \<0.001   0.229                     0.556
  IPI              Low         High             0.326          \<0.001   0.212                     0.494

IPI, inflammatory prognostic index; CEA, carcinoembryonic antigen; CYFRA21-1, cytokeratin 19 fragments; CI, confidence interval; AD, adenocarcinoma; SCC, squamous cell carcinoma.

The 5-year overall cancer-specific survival was 74.9% in our study. As shown in [Figure 1](#F1){ref-type="fig"}, patients with high IPI had a significantly poor 5-year cancer-specific survival compared to low IPI (57.9% vs. 84.8%, p\<0.001).

![Overall Postoperative Cancer-Specific Survival of Patients based on Inflammatory Prognostic Index (IPI).](APJCP-19-2867-g001){#F1}

By univariate analysis, gender, smoking status, histology, pT status, pN status, serum CEA level, serum CYFRA21-1 level, serum CRP level and IPI were significant association with the 5-year cancer-specific survival. All 8 clinicopathological characteristics were further investigated in multivariate analysis. As shown in [Table 3](#T3){ref-type="table"}, gender (p=0.009), histology (adenocarcinoma vs. squamous cell carcinoma: p\<0.001, adenocarcinoma vs. others: p=0.001), pN status (p=0.001), serum CEA level (p=0.002) and IPI (p\<0.001) were independent factors in predicting overall postoperative cancer specific survival, while smoking status, pT status and serum CYFRA21-1 level were not.

###### 

Multivariate Analysis

                   Favorable   Unfavorable      Hazard ratio   p Value   95% confidence interval   
  ---------------- ----------- ---------------- -------------- --------- ------------------------- -------
  Gender           Female      Male             0.422          0.009     0.214                     0.81
  Smoking status   Never       Current/former   0.781          0.489     0.396                     1.584
  Histology        AD          SCC              0.42           \<0.001   0.263                     0.676
                   AD          Others           0.306          0.001     0.169                     0.584
                   SCC         Others           0.607          0.159     0.31                      1.223
  pT status        pT1         pT2-3            0.967          0.893     0.6                       1.58
  pN status        pN0         pN1-2            0.365          0.001     0.214                     0.635
  CEA              Normal      High             0.473          0.002     0.302                     0.748
  CYFRA21-1        Normal      High             0.783          0.357     0.473                     1.326
  IPI              Low         High             0.438          \<0.001   0.276                     0.69

IPI, inflammatory prognostic index; CEA, carcinoembryonic antigen; CYFRA21-1, cytokeratin 19 fragments; CI, confidence interval; AD, adenocarcinoma; SCC, squamous cell carcinoma.

Discussion {#sec1-4}
==========

To our knowledge, this was the first report investigating the prognostic value of IPI in resected patients with NSCLC. In this study, we revealed that IPI was an independent significant predictive factor for resected NSCLC.

The systemic inflammation response of the host is one of the representative biomarkers of host-related factors that predict the prognosis of cancer (Scott et al., 2002). A significant positive correlation between serum CRP level and progression of NSCLC has been reported (Jing et al., 2015). High serum CRP level has also been associated with increased weight loss, reduced performance status, increased fatigue and decreased survival (Jing et al., 2015). Based on these findings, high serum CRP level may predict poor survival.

Neutrophils influences tumor initiation and progression in the tumor microenvironment and impede the activity of lymphocytes and other immune cells, whereas lymphocytes suppress tumor growth and invasion through their cytolytic activity, and was associated with a survival benefit (Gooden et al., 2011). A high NLR is detected when the absolute neutrophil count is high and the absolute lymphocyte count is low. Therefore, high neutrophil may aid in the development and progression of tumor and a relative lymphocytopaenia may exhibit a poorer lymphocyte mediated immune response to tumor.

Low serum albumin could represent the compromised nutritional status of the host, as well as the response of systemic inflammation (Sun et al., 2015; Espinosa et al., 1995). Previous studies demonstrated that hypoalbuminemia was associated with poor prognosis and decreased survival in NSCLC (Sun et al., 2015; Espinosa et al., 1995).

Taken together, the combination of CRP, NLR and serum albumin may serve as a more effective scoring system to predict prognosis of NSCLC patients. Thus, a high IPI, due to high levels of serum CRP and neutrophils while low level of lymphocytes and serum albumin, suggests a stronger inflammatory and a weaker immune response in patients. It may be associated with invasion and metastasis of cancer cells and hence lead to poor survival.

In the present series, IPI was significantly associated with age, gender, smoking status, histology, pT status and CYFRA21-1, but not pStage, pN status and serum CEA level. This indicated that IPI does not always correlate with more advance and aggressive disease phenotypes. Furthermore, the results of multivariable analysis showed that IPI is an independent prognostic factor.

IPI was based on four factors (CRP, neutrophil, lymphocyte and albumin) (Dirican et al., 2016), while GPS, NLR, PLR and PNI, were based on two factors (Jin et al., 2017; Gu et al., 2015; Qiang et al., 2016; Okada et al., 2017). IPI should be a more objective marker that reflects the balance between host inflammatory and immune response status than all the other systemic inflammation scores.

IPI is simple, inexpensive and it doesn't require extra equipment. Thus, IPI should be taken into consideration in the therapeutic program for resected NSCLC. It would be very useful to carry extensive study in several countries for better conclusions and recommendations.

Our study had several limitations. It was a single-center, retrospective study with a relatively small sample size. A new cutoff value might be got when we examine it in large number of cases. Thus, conclusions from the present study may have a bias, indicating that prospective cohort and multicenter studies to find a proper cutoff value are needed.

In conclusions, to the best of our knowledge, this is the first report to demonstrate the prognostic role of IPI in patients with resected NSCLC.

Conflict of interest {#sec2-2}
--------------------

The authors have declared that no conflict of interest exists.
